Cardiovascular risk factors, radiation therapy, and myocardial infarction among lymphoma survivors.
Talya SalzEmily C ZaborPeter de Nully BrownSusanne Oksbjerg DaltonNirupa J RaghunathanMatthew J MatasarRichard SteingartHenrik HjalgrimLena SpechtAndrew J VickersKevin C OeffingerChristoffer JohansenPublished in: Acta oncologica (Stockholm, Sweden) (2022)
Patients with CVRFs have an importantly higher risk of subsequent MI if they have mediastinal radiation. Routine evaluation of CVRFs and optimal treatment of preexisting cardiovascular disease should continue after receiving cancer therapy. In patients with CVRFs, mediastinal radiation should only be given if oncologic benefit clearly outweighs cardiovascular harm.
Keyphrases
- cardiovascular risk factors
- cardiovascular disease
- cancer therapy
- radiation therapy
- lymph node
- metabolic syndrome
- radiation induced
- ultrasound guided
- heart failure
- young adults
- left ventricular
- diffuse large b cell lymphoma
- clinical practice
- rectal cancer
- cardiovascular events
- robot assisted
- squamous cell carcinoma
- coronary artery disease
- minimally invasive
- atrial fibrillation
- replacement therapy